Accordingly, the levels of E2F1 were significantly increased in TACO expressing HCC tissue (Fig. 5b, Supplementary Fig. S2c), suggesting that HBV CP mutations may induce hepatocarcinogenesis and tumour progression via similar mechanisms. The gene discussed is E2F1; the disease is neoplasm.